Bioactive peptides for nutrition

01Overview and value chain#

Markers EC: Food Supplements Directive 2002/46/EC | OECD: Food Systems | Regulator: FDA (USA), EFSA (EU), NMPA (China)

Bioactive peptides are short chains of 2–20 amino acids, locked inside large plant or animal protein globulins in their native state but released as potent cell-signalling molecules once freed. Unlike bulk dietary protein that serves mainly as a plastic amino-acid source, these peptides act on receptors in the gut, immune system, vasculature and muscle, triggering specific metabolic cascades. The 2026 industry is defined by an AI-discovery revolution: generative platforms such as Nuritas Magnifier and Brightseed Forager scan trillions of candidate sequences in plant genomes, predicting bioactivity, gastrointestinal stability and target binding, and compressing ingredient discovery from a 5–7 year wet-lab campaign to a matter of months. The flagship plant peptide complex PeptiStrong, isolated by AI from faba bean (Vicia faba), down-regulates the muscle-atrophy genes Atrogin and MURF1 and has cleared FDA GRAS for use in foods, drinks and supplements.

The key directions of bioactive peptides for nutrition are:

1. AI-peptide discovery (AI-Peptide Discovery): deep-learning screening of plant genomes for latent bioactive motifs, cutting lead time from 5–7 years to months.
2. Targeted enzymatic hydrolysis (Targeted Enzymatic Hydrolysis): controlled proteolysis with bespoke protease cascades that cut the protein only at AI-specified sites, yielding a defined peptide pattern.
3. Membrane downstream fractionation (Membrane Downstream Fractionation): tangential-flow ultrafiltration with a sharp molecular-weight cut-off (<3 kDa) that isolates ultra-short signalling peptides from larger allergenic fragments.
4. Functional nutrition formats (Functional Nutrition Formats): GRAS-grade peptide ingredients formulated into sports recovery, sarcopenia/longevity, infant and enteral-clinical products.

Sectoral value chain#

[AI Proteolysis Design] ──> [Protein Extraction] ──> [Targeted Hydrolysis]
           │                          │                         │
     (Magnifier / Forager)     (faba bean, rice,          (AI-specified proteases)
                               soy, oat)                          │
                                                                  ▼
[B2B Supplements / Nutrition] <── [Drying & Packing] <── [Membrane Downstream]

Value chain levels#

Cross-cutting technologies of the sector:

• Deep-learning QSAR for peptide activity (Deep-Learning QSAR): neural networks trained on biological data to predict gastrointestinal stability and bioavailability.
• Molecular-weight-controlled hydrolysis (MW-Controlled Hydrolysis): precision arrest of proteolysis (thermal inactivation, rapid pH shift) to prevent over-degradation to free amino acids.
• Tangential-flow ultrafiltration (Tangential-Flow Ultrafiltration): industrial membrane cascades separating undigested protein and allergenic peptides from ultra-short signalling peptides.

02US#

The US leads commercial deployment of AI-discovered peptides, building a large market in functional sports nutrition, geroprotective formulas against sarcopenia, and personalized nutraceuticals, anchored by a Silicon-Valley venture hub at the intersection of generative AI and nutrition.

GRAS clearance, sports & longevity nutrition, AI-peptide venture hub#

• FDA GRAS notifications: Nuritas PeptiStrong cleared the FDA GRAS process, removing restrictions on its use in foods, beverages and supplements across the United States.
• Sports nutrition & longevity: PeptiStrong became a premium recovery ingredient and a sarcopenia-prevention nutraceutical for ageing adults, while Brightseed scaled Forager-discovered phytonutrients with healthy-food brand partners.
• AI-peptide venture hub: the majority of funds and accelerators financing generative-AI-meets-nutrition start-ups are concentrated in the US, making it the sector’s main technology driver.

03CN#

China is scaling bioactive peptides as a key tool against an ageing demographic profile and to raise the value-added processing of its agricultural crops, with a focus on traditional Asian feedstock and large-volume clinical and infant nutrition.

traditional feedstock peptides, infant & clinical nutrition, MARA standardization#

• Peptides from traditional feedstock: research centres, including the Chinese Academy of Agricultural Sciences, derive bioactive peptides from soy, rice, wheat, ginseng and marine organisms, with domestic AI screening platforms for medicinal-herb phytochemistry.
• Infant & clinical nutrition: deep-hydrolysis peptides are widely built into hypoallergenic infant formula and enteral clinical-nutrition products for bedridden and post-surgical patients.
• Standardization & state regulation: MARA and the National Health Commission are developing national standards for functional peptides to order a fast-growing market and protect consumers from adulteration.

04EU#

The European Union prioritizes scientific evidence, safety and environmental sustainability of peptide ingredients, acting as the principal R&D base for fundamental peptidomics research and AI-discovery start-ups.

R&D base & peptidomics, EFSA health-claim control, Green Deal upcycling#

• R&D cradle: Nuritas was founded by Nora Khaldi in Dublin with European grant support and the Irish National Institute for Food Research; Ireland and Denmark remain the key fundamental peptidomics centres, alongside University College Dublin research on plant hydrolysates and metabolic-syndrome markers.
• Strict EFSA control: health claims for peptides undergo the most rigorous EFSA verification, requiring randomized placebo-controlled clinical evidence that screens out pseudo-scientific supplements.
• Green Deal agenda: peptide production is framed as part of the transition to sustainable plant feedstock, with enzymatic upcycling of food-industry side streams from oat, pea and lupin subsidized under Horizon Europe.

05Leading companies and research institutes#

06Tech stack and innovations#

The AI-peptide stack fuses generative bioinformatics with precision bioprocess engineering, where a 1 °C temperature or 0.1 pH shift at the hydrolysis step can change the protease cleavage site and destroy a batch’s bioactivity.

1. AI platforms and predictive modelling (In-Silico Prediction):
   • deep convolutional networks analyze plant protein structure to flag fragments that, once released, interact with cell receptors (e.g. down-regulating NF-kB-driven inflammation).
   • digestion simulation filters for resistance to pepsin, trypsin and gut peptidases, keeping only motifs that reach the intestine intact and absorbable.
2. Precision enzymatic hydrolysis (Precision Enzymatic Hydrolysis):
   • given the AI cleavage map, technologists deploy commercial proteases (e.g. alcalase, papain, thermolysin) in reactors with tight parameter hold, because a 1 °C or 0.1 pH deviation shifts the cut site.
   • the reaction is arrested by rapid heating to 90 °C for 10 min, irreversibly denaturing the proteases before peptides degrade to inactive free amino acids.

07Value chains and production pipelines#

Industrial pipeline of directed hydrolysis of bioactive peptides (ISO 22000)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. AI modelling and       │ ───> │ 2. Extraction and         │
│    protease selection     │      │    isolate dissolution    │
└───────────────────────────┘      └───────────────────────────┘
                                                  │
                                                  ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Thermal inactivation   │ <─── │ 3. Enzymatic hydrolysis   │
│    (reaction arrest)      │      │    (pH, temperature)      │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Ultrafiltration        │ ───> │ 6. Spray-drying and       │
│    (>3 kDa cut-off)       │      │    bioactivity grading    │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: AI design and protease selection

The Magnifier platform models the cleavage of faba bean protein and selects a specific cascade of two commercial bacterial proteases that excise the PeptiStrong peptide pattern with minimal formation of free amino acids.

Stage 2: Isolate preparation and dissolution

Plant faba-bean isolate with >85% protein is dissolved in deionized water to 10% dry solids, heated to 55 °C and set to pH 8.0 with sodium-hydroxide dosing for the first protease.

Stage 3: Directed controlled proteolysis

The first protease is dosed in and hydrolysis runs for 4 hours under continuous mixing, with a pH-stat auto-dosing alkali to neutralize freed carboxyl groups; a second protease then finishes cutting the peptide chains.

Stage 4: Thermal inactivation of enzymes

To stop the peptides degrading to inactive free amino acids, the mass is flash-heated to 90 °C and held for 10 minutes, irreversibly denaturing the proteases.

Stage 5: Microfiltration and cascaded ultrafiltration

The hydrolysate is cooled to 45 °C, centrifuged to remove insoluble fibre, then pumped through a tangential-flow cascade: a 10 kDa membrane removes undigested protein and denatured enzyme, and a 3 kDa membrane removes mid-size peptides, leaving a permeate of ultra-short signalling peptides under 3 kDa.

Stage 6: Concentration, drying and packing

The peptide solution is vacuum-concentrated to 35% solids and spray-dried (175 °C inlet, 80 °C outlet); the light-cream hygroscopic powder at <4% moisture is packed in nitrogen-flushed foil pouches for B2B delivery to sports-nutrition and supplement manufacturers.